MedTrace Logo

Evaluation of Pandemic Vaccination Campaign

NCT01024725 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3518

Last updated 2014-09-25

No results posted yet for this study

Summary

A cohort of 4000 community-dwelling adults is followed to evaluate the effectiveness of the Finnish national A(H1N1)v influenza vaccination campaign in preventing the first episode of laboratory-confirmed A(H1N1)v influenza. The safety of vaccination and the severity of the disease are followed primarily from health care registers. In a subgroup of 200 participants, the humoral and cellular immunogenicity of the vaccine will be studied.

Conditions

  • Influenza Caused by the Novel A(H1N1)v Influenza Virus

Interventions

OTHER

Follow-up

Nasopharyngeal/oropharyngeal and blood samples, interviews, questionnaires, register data

Sponsors & Collaborators

  • Finnish Institute for Health and Welfare

    lead OTHER_GOV

Principal Investigators

  • Terhi M Kilpi, MD PhD · Finnish Institute for Health and Welfare

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2010-04-30
Completion
2014-09-30

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01024725 on ClinicalTrials.gov